✦ LIBER ✦

Advances in the therapy of gastric cancer

✍ Scribed by John S. Macdonald

Publisher: Springer
Year: 2002
Tongue: English
Weight: 148 KB
Volume: 5
Category: Article
ISSN: 1436-3291
DOI: 10.1007/s10120-002-0205-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase ii study of the combination of e

A phase ii study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancer

✍ Thomas E. Elliott; Charles G. Moertel; Harry S. Wieand; Richard G. Hahn; James B 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB 👁 2 views

Forty-eight patients with advanced gastric cancer and measurable areas of malignant disease were treated with etoposide (130 mg/mz/day X 3 days) plus cisplatin (45 mg/mzday on days 2 and 3). Both drugs were given by constant intravenous infusion and repeated every 4 weeks. Common toxic reactions inc

A phase II study of combination therapy

A phase II study of combination therapy with 5′-deoxy-5-fluorouridine and cisplatin in the treatment of advanced gastric cancer with primary foci

✍ Wasaburo Koizumi; Minoru Kurihara; Tadashi Sasai; Shigeaki Yoshida; Kimitomo Mor 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB

Background. 5'-Deoxy-5-fluorouridine (5'-DFUR, doxifluridine) is a recently developed prodrug of oral From the Japan Gastric Cancer Study Group,

A phase II study of biweekly mitomycin C

A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial)

✍ Tetsuya Hamaguchi; Kuniaki Shirao; Atsushi Ohtsu; Ichinosuke Hyodo; Yasuaki Arai 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 341 KB

Neoadjuvant therapy of locally advanced

Neoadjuvant therapy of locally advanced gastric cancer

✍ James J. Mezhir; Laura H. Tang; Daniel G. Coit 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB

## Abstract Treatment of gastric cancer has evolved with the advent of randomized trials demonstrating chemotherapeutic agents with efficacy in advanced disease. Level I evidence supports delivering chemotherapy in the neoadjuvant setting; the data shows improvement in progression‐free and overall

Diagnosis of advanced gastric cancer

✍ Fusahiro Nagao; Nobuhiro Takahashi 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 761 KB

Modified therapy with 5-fluorouracil, do

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

✍ Andre M. Murad; Flavia F. Santiago; Andy Petroianu; Paulo R. S. Rocha; Marco A. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB